ADAM17 and ovarian carcinoma: In this study, we provide evidence that activity of ADAM17 and expression as well as shedding of the ADAM17 substrate AREG increase subsequently to chemotherapeutic treatment thus playing an important role in EGFR and ERK dependent chemo-sensitization of ovarian cancer cells.